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The fundamental studies of Landsteiner and his coworkers  (1)  on 
complex antigens have  established  the important principle that  the 
introduction into the protein molecule of a simple non-protein radical 
confers a  new immunological specificity on the antigenic compound. 
Furthermore, this newly acquired specificity has been shown to depend 
upon the nature of the new chemical grouping thus introduced. 
Previous studies from this laboratory (2) on the chemo-immunologi- 
cal properties of "synthetic antigens," prepared by combining a simple 
carbohydrate  radical  with  protein,  have  shown  that  the  specificity 
of the newly formed compounds is determined in each instance by the 
chemical individuality  of  the  reactive  carbohydrate,  irrespective  of 
the  protein to which it is  attached.  Simple  derivatives  of  glucose 
and  galactose,  which  by  themselves  are  non-antigenic  will,  when 
coupled to a  common protein, stimulate the formation of antibodies 
that  are  specific for the  particular  sugar  used.  Antisera,  produced 
by immunization with the conjugated sugar-proteins,  invariably re- 
flect the controlling influence of the  carbohydrate on  the specificity 
of the whole antigen.  So sensitive is this chemo-specific effect, that 
mere differences in the spatial arrangement of the groups on a  single 
carbon atom in two glucosides otherwise identical, were found suffici- 
ent  to  change completely the  antigenic specificity of the  respective 
compounds. 
In order to test the possibility of synthesizing a specific antigen by 
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combining a bacterial carbohydrate with a foreign protein, the specific 
capsular  polysaccharide  of  Type  III  Pneumococcus was  purposely 
chosen, since in its purified form it contains no nitrogen and may be 
regarded as a  definite chemical entity.  Further, if results were ob- 
tained  by  the  use of  this  particular  bacterial  polysaccharide,  they 
would be the more significant, since the isolated pure substance alone 
has never been found to elicit antibodies in rabbits,  and even the irr- 
tact bacterial  cells from which it is derived commonly fail to incite 
the formation of type-specific antibodies in these animals. 
From a  chemical point of view,  the difficulty lay in synthesizing 
the appropriate  derivative of the capsular polysaccharide.  It must 
be one capable of coupling with protein on diazotization and one in 
which the chemo-specific groups of the bacterial sugar are not masked 
or destroyed in its preparation.  The details of the chemical methods 
used in the synthesis of the aminobenzyl ether of the capsular poly- 
saccharide of Type III Pneumococcus have been described in the pre- 
ceding paper  (3).  The  diazonium derivative  of  the polysaccharide 
was coupled with globulin prepared from horse serum, and the newly 
formed compound was tested for antigenicity by repeated intravenous 
injection in rabbits.  The sera of the immunized animals were tested 
for the presence of type-specific agglutinins and protective antibodies 
against encapsulated, virulent strains of Type IiI Pneumococcus and 
for precipitins against  the type-specific capsular polysaccharide and 
its aminobenzyl derivative.  The treated  rabbits  were subsequently 
infected with a  rabbit-virulent  strain  of Type III Pneumococcus to 
determine whether,  as  a  result of immunization, they had  acquired 
active immunity against Type III infection. 
In evaluating the immunological findings presented in this paper, 
the fact should be borne in mind that the antigen used in the experi- 
ments has in common with the Type III Pneumococcus only the spe- 
cific capsular polysaccharide, and that the protein with which it is con- 
jugated is of widely remote biological origin. 
EXPERIMENTAL 
Methods 
Immunizatlon.--Rabbits were immunized by the intravenous injection of from 
1 to 2 cc. of solutions of the conjugated carbohydrate-protein antigen daily for OSWALD  T. AVERY  AND  WALTHER  F.  GOEBEL  439 
six doses, and the course of injections was repeated a second time after a rest pe- 
riod of 7 days.  8 days after the last injection the rabbits were bled and the serum 
tested for type-specific pneumococcus antibodies. 
Antigen.--The antigen, prepared as described in the preceding paper, was pre- 
served by the addition of 0.25 per cent tricresol.  Each preparation was standard- 
ized on the basis of nitrogen content, so that 1 cc. of the solution contained 5 mg. 
of protein.  This method, however,  does not indicate the amount of bound car- 
bohydrate and hence is not an accurate measure of the effective antigenic com- 
plex.  The protein, to which the aminobenzyl ether derivative of Type III poly- 
saccharide was  bound by the diazo reaction, was globulin prepared from horse 
serum by precipitation with ammonium sulfate. 
Technic of Immunity Reactiom.--In the precipitin reactions, the immune serum 
• was diluted in the proportion of two parts of serum to three of salt solution and 
0.5 cc. of this dilution containing 0.2 cc. of original serum was added to 0.5 cc. of 
varying dilutions of reacting substance.  The final concentration of precipitino- 
gen in the reaction mixture is shown in the protocols.  The protection tests were 
done by the usual technic; mice were injected intraperitoneally with 0.2 cc. im- 
mune serum together with varying dilutions of an actively growing  culture of 
Pneumococcus.  The dilutions were so made that the total volume injected was 
1 cc. in all instances. 
I.  Type-Specific A nti  pneumococcus Antibodies 
1.  Precipitins.--The  sera of rabbits immunized with the  Type nI 
"synthetic antigen" were tested for the presence of precipitins for the 
original capsular polysaccharide and for the aminobenzyl ether deriv- 
ative  used  in  preparing  the antigen.  The introduction of the para- 
aminobenzyl radical into the polysaccharide molecule did not destroy 
the immunological specificity of the derivative, since the latter reacted 
with  Type  In  antipneumococcus  horse  serum  in  high  dilutions, 
showing a  specific reactivity comparable to that of the original poly- 
saccharide from which it was derived.  It was of interest, therefore, to 
determine whether this specific carbohydrate derivative, when bound 
with  protein,  would  stimulate  the  formation  of precipitins  reactive 
not only with the amino derivative but also with the polysaccharide 
itself, when both substances were used in the free, soluble form. 
The precipitin reactions of immune rabbit serum with the original 
and modified form of the Type In  capsular polysaccharide are com- 
pared in Table I.  The results show  that  the serum of a  rabbit im- 
munized with the "synthetic antigen" reacts with the native polysac- 
charide  and  with  its  aminobenzyl  ether  in  equally  high  dilutions. 440  CONJUGATED  CARBOHYDRATE-PROTEINS.  V 
Similarly, as previously pointed out, the serum of a horse immunized 
with the intact bacterial cells containing the natural Type III antigen 
precipitates the polysaccharide derivative as well as it does the poly- 
saccharide  itself.  The  evidence is,  therefore,  that  the  specifically 
reactive groups of the polysacch£ride have not been chemically masked 
in forming the new derivative, and that when this specifically reactive 
carbohydrate is chemically bound with protein to form a new antigen, 
it orients the immune response as specifically as does the polysaccha- 
ride itself in the form in which it exists as a natural antigen in the en- 
capsulated ceils. 
TABLE  I 
Precipitins for the Capsular Polysacckaride of Type III Pneumococcus in Serum 
of Rabbits Immunized witk Type HI Synthetic Antigen 
Dilution of carbohydrate  Purified  preparation  of Type III  Amlnobenzyl  ether ot Type III 
polysaceharlde  polysaccharide 
1:100,000 
1:200,000 
1:400,000 
1:800,000 
1:1,600,000 
+++ 
+++ 
+++ 
+± 
+ 
+++ 
+++ 
+++ 
+ 
-b +-b  = complete precipitation with compact disc. 
-t-+  -- diffuse turbidity. 
-b  = slight turbidity. 
2.  Agglutinins.--The  sera of rabbits,  prepared by serial injections 
of the chemically combined antigen, specifically agglutinate encapsu- 
lated strains of Type III pneumococci. 
The results of the agglutination reactions,  as illustrated in Table 
II, show that while the titre of agglutinins is not high, the serum is 
type-specific in that it agglutinates only Type III pneumococci, and 
fails to react with organisms of Type I  and Type II.  The fact that 
the immune serum does not agglutinate the non-encapsulated R forms 
of Pneumococcus was to be expected, since the antigen contains none 
of the  somatic  constituents  commonly present in  all  pneumococci. 
The lack of these cellular substances in the artificial antigen is reflected 
in the serum by the absence of the species-specific antibodies, which OSWALD  T.  AVERY  AND  WALTHER  F.  GOEBEL  441 
are ordinarily present when the whole cell is used  as  the immunizing 
agent. 
TABLE  II 
Specificity  of Agglutination  Reaction with Serum of Rabbit Immunized with Type 
IH Synthetic Antigen 
Pneumococcus 
Type I ....................... 
Type II .................... 
Type III ................... 
R  strata  .................. 
I:S 
D 
++++ 
Immune  serum 
1:10  1:20 
+++  + 
1:40 
4- 
+  +  +  +  =  complete agglutination with disc formation. 
-  =  no reaction. 
* Derived from Pneumococcus Type II. 
TABLE  III 
Protective Action  in Mice of Sera of Rabbits Immunized with Type III Synthetic 
Antigen 
Pneumococcus 
Type  In 
co. 
0.01 
0.001 
0.0001 
0.00001 
0.000001 
0.0OOOOO1 
0.00000001 
Immune  rabbit sera  (0.2 cc.) 
(a) 
S  S 
S  S 
S  S 
(b) 
S  S 
S  S 
S  S 
(c) 
D 22  D 22 
S  S 
S  S 
S  S 
S  S 
(d) 
D  7  D24 
S  S 
S  S 
S  S 
S  S 
Virulence 
controls 
No serum 
I 
D 42  D 42 
D 42  D 45 
D75  D45 
S  =  survival. 
D  =  death ofanimal, thenumeralindicates  thenumberofhourselapsingbefore 
death. 
-  =  not done. 
3.  Protective  Antibodies.--To  ascertain  whether  passive  immunity 
against  pneumococcus  infection  could  be  conferred  on  mice  by  the 
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III antigen, protection tests were carried out by the technic described. 
A constant amount of immune serum (0.2 cc.) was injected intraperi- 
toneally into mice together with varying quantities of a virulent cul- 
ture of Pneumococcus. 
The results given in Table III show that the immune rabbit sera 
were effective in protecting mice against 10 -3 cc. of a virulent culture 
TABLE  IV 
Type Specificity of Protective Antibodies in the Sera  of Rabbits Immunized  with 
Type III Synthetic Antigen 
Immune serum 
CC. 
0.2 
0.2 
0.2 
0.2 
Virulence controls 
Amount of culture 
10-3 
10-4 
10-6 
lO-e 
10-6 
I0-' 
10-8 
Pneumococcus 
Type I 
D28  D28 
D46  D28 
D28  D46 
D  46 
D  72 
st 
Type II 
D28  D28 
D28  D46 
D28  D28 
D28 
D~ 
D46tt 
Type III 
S  S 
S  S 
S  S 
S  S 
D  45 
D  46 
D46ttt 
S  =  survival. 
D  = death of animal; the numeral indicates the  number of  hours elapsing 
before death. 
-  =  not done. 
The number of colonies developing in blood agar seeded with this inoculum 
0. 
~  The number of colonies developing  in blood agar seeded with this .inoculum 
3. 
~  The number of colonies developing  in blood agar seeded with this inoculum 
~2. 
of Type  III Pneumococcus, of which 10 -8  cc.  was invariably fatal 
when injected alone into  untreated  control animals.  Although the 
maximum degree of protection afforded by the serum was not high, 
the special interest of these experiments lies in the fact that the pro- 
tective antibodies were produced in response to a  combined antigen 
containing a  specifically reactive carbohydrate which by itself fails 
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The  specificity of the  protective antibodies in  the  sera of rabbits 
immunized with the Type III synthetic antigen is shown in Table IV. 
The protective action of the immune serum is strictly type-specific. 
Mice receiving the immune  serum survived infection with Type III 
Pneumococcus, but succumbed promptly to minimum  doses of Type 
I  or Type II  culture.  The marked  specificity of the  protection af- 
forded by the serum is further evidence that the antibodies concerned 
in the reaction derive their  specificity from the polysaccharide com- 
ponent of the whole antigen.  The protein constituent of the antigen 
appears  to  contribute  nothing  to  the  antibacterial  properties of the 
serum,  except in  so far as it renders  the carbohydrate antigenic. 
4. Active Immunity.--Of the  series of rabbits  injected  at  various 
times  with  effective preparations  of  antigen,  none  have  failed  to 
respond  with  the  formation  of  type-specific antibodies.  It  was  of 
interest,  therefore,  to ascertain  whether rabbits in the sera of which 
Type III Pneumococcus antibodies were demonstrable had acquired 
active immunity  against  infection with this  organism.  In  order  to 
determine this point, several of the treated animals were subsequently 
infected with multiple lethal doses of a  virulent culture  of  Type  IU 
Pneumococcus. 
11 days after the last injection of antigen, four immunized rabbits whose serum 
contained type-specific antibodies were infected by the intradermal  injection of 
0.2 cc. of an 18 hour blood broth culture of a rabbit-virulent  strain of Type III 
Pneumococcus.  The  virulence  of this  strain,  maintained  by repeated  rabbit 
passage, was such that 0.00001 cc. of the culture alone injected into the skin proved 
fatal within 72 hours. 
Four rabbits, which had received repeated injections of the "synthetic 
antigen,"  were  reserved and later  tested for active immunity.  All 
four of these rabbits survived infection.  In the two animals  which 
had  the  highest  titre  of type-specific antibodies in  their  serum,  the 
infection ran  a  practically afebrile course with only a  slight  inflam- 
matory reaction at the point of inoculation; in the other two rabbits, 
the temperature remained relatively low and the skin lesion was not 
severe.  At no time during the course of the infection were pneumo- 
cocci  present  in  cultures  of  the  blood  of  the  immunized  rabbits, 
whereas in  the normal  controls  the  bacteremia invariably increased 
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The results demonstrate that  an  antigen prepared by combining 
the Type III capsular polysaccharide with an animal protein is cap- 
able of inducing in rabbits an active immunity against infection with 
a virulent culture of Type III Pneumococcus.  The only constituent 
of Pneumococcus in the artificial antigen is the capsular polysaccha- 
ride.  Since this carbohydrate alone is non-antigenic in rabbits,  the 
antibacterial  immunity induced  by  the  combined  antigen  can  be 
ascribed  only  to  the  antigenicity  acquired  by  the  polysaccharide 
through  combination with  the  foreign  protein.  The  results  bring 
evidence that an effective, active immunity can be developed in which 
the only antibacterial  antibodies formed are  those directed against 
the capsular component of the pneumococcus. 
If.  Antlprotein Antibodies 
In the conjugated antigen, the protein used in combination with the 
Type III capsular polysaccharide was globulin derived from normal 
horse serum.  The total protein of the antigen was estimated by de- 
termining the  nitrogen  content of  the  various  preparations.  This 
method of standardization,  while affording a  measure of the  total 
globulin present, does not indicate the amount of protein that is bound 
with the polysaccharide to form the effective type-specific antigen. 
The  sera  of  immune rabbits  invariably  contained  not  only  type- 
specific  antibodies  for  Type  III  Pneumococcus,  but  also  specific 
precipitins for the globulin of horse serum. 
The presence in immune rabbit  serum of precipitating antibodies 
for the foreign protein used in  preparing the  antigen  is  shown  in 
Table V.  The antiprotein precipitins evoked by the combined anti- 
gen may be attributed to one or both of two possibilities.  In the first 
place,  despite attempts to  remove the  excess  of unbound globulin 
from solution, it is possible that sufficient protein remains free and 
uncombined with  the  polysaccharide to  function independently as 
antigen.  It is also possible, however, that even in the absence of any 
free globulin, the combined antigen itself may give rise to two quali- 
tatively different antibodies,  each specifically related to  the  corre- 
sponding component of the antigenic complex.  This explanation of 
the  concurrence of  two  distinct varieties  of  antibodies in  the  im- 
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has acquired antigenicity through combination with the globulin, the 
protein molecule itself has not lost its own specific antigenic property. 
According to this view, a  single compound of carbohydrate and pro- 
tein  may  possess  the  dual  antigenic  property  of  stimulating two 
separate and specific antibodies; one evoked by the newly acquired 
antigenicity of the polysaccharide in union with globulin, and the other 
stimulated by the protein molecule itself in which the chemo-specific 
groups essential for antigenicity have not been masked in the linkage 
with the carbohydrate. 
TABLE  V 
Antiglobulin  Precipitins  in Sera  of Rabbits Immunized  witk  Type III  Synthetic 
A~igen 
Globulin (horse  serum)* 
Immune sera 
(a) 
(b) 
(c) 
(d) 
(e) 
1: 20,000 
+++ 
+++4- 
++++ 
++++ 
+++4- 
1:40,000 
+++ 
+++ 
+++4- 
+++ 
++± 
1:80,000 
++ 
++ 
+4- 
++ 
+ 
1:160,000 
4- 
+ 
4- 
+ 
4- 
+ + + +  ~  flocculent precipitation, clear supernatant. 
+  -  slight, diffuse turbidity. 
* The diazonium derivative of the capsular polysaccharide of Type III Pneu- 
mococcus  was coupled with globulin from horse serum. 
Of the two explanations, the first, namely that the free globulin in 
the antigenic mixture accounts for the antiprotein antibodies, is the 
simpler and perhaps the more likely one.  However, the second con- 
cept, which ascribes a  dual antigenicity to the sugar-protein, affords 
an immunologically interesting and theoretically possible explanation. 
DISCUSSION 
In the present state of our knowledge it would be hazardous to pre- 
dict  the precise conditions  under which complex carbohydrates by 
themselves  may  function  as  antigens.  The  present  study  simply 
defines  certain  experimental  conditions  under  which  the  capsular 
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foreign protein, is rendered specifically antigenic in a particular species 
of animals, in which the carbohydrate alone has never been found to 
incite antibody formation.  The "synthetic antigen" elicits in rabbits 
a  type-specific antipneumococcus response, which neither one of its 
constituents  alone is  capable  of inciting when injected singly into 
these animals. 
In order to effect the chemical union, it was first necessary to syn- 
thesize a derivative of the bacterial carbohydrate that could be diazo- 
tized and coupled to protein by means of the diazo linkage.  This 
was accomplished by forming the aminobenzyl ether of the polysac- 
charide,  a  derivative which fulfills the chemical requirements while 
still retaining the serological specificity of the original carbohydrate. 
Antisera prepared by immunization with the combined antigen con- 
tain type-specific antibodies which precipitate the Type III capsular 
polysaccharide,  agglutinate  pneumococci  of  the  homologous  type, 
and protect mice against infection with virulent strains of Type III 
Pneumococcus.  The fact that, in the present instance, the antipneu~ 
mococcus response is produced by an antigen known to contain but a 
single component of the bacterial cell, indicates the unity of the anti- 
bodies participating in the type-specific reactions of precipitation, ag- 
glutination, and protection, and relates the specificity of these anti- 
bodies to that of the capsular polysaccharide in the reactive part of 
the antigenic molecule. 
CONCLUSIONS 
1.  Type-specific antipneumococcus immunity has been induced in 
rabbits by immunization with antigen prepared by combining a specific 
derivative of the capsular polysaccharide of Type III Pneumococcus 
with globulin from horse serum. 
2.  Rabbits immunized with this antigen acquire active immunity 
against infection with virulent Type III pneumococci. 
3.  The sera of the immune rabbits contain type-specific antibodies 
which precipitate the Type III capsular polysaccharide, agglutinate 
Type III pneumococci, and specifically protect mice against Type III 
infection. 
4.  The experimental data are discussed with reference to:  (1)  the 
concurrence in the immune sera of type-specific antibodies for Pneu- OSWALD T.  AVERY AND  WALTHER F.  GOEBEL  447 
mococcus and precipitins for horse globulin;  (2) the determining influ- 
ence of the capsular  polysaccharide  on the specificity of the antigen 
as a  whole;  (3) the unity of the type-specific precipitins,  agglutinins, 
and protective antibodies induced by a single compo~aent of the pneu- 
mococcus in chemical union with  an unrelated,  animal  protein. 
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